Search results
Results from the WOW.Com Content Network
Seres Therapeutics (MCRB) delivered earnings and revenue surprises of -22.22% and 62.94%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Do the numbers hold clues to what lies ahead for the stock? Seres Therapeutics (MCRB) delivered earnings and revenue surprises of 253.19% and 1681.10%, respectively, for the quarter ended ...
Investors need to pay close attention to Seres Therapeutics (MCRB) stock based on the movements in the options market lately.
CAMBRIDGE, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that management will host a conference call and live audio webcast on November 13, 2024 at 8:30 a.m. ET to discuss third quarter 2024 financial results and provide business updates.
CAMBRIDGE, Mass., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), (“Seres” or the “Company”), a leading live biotherapeutics company, today announced that its stockholders voted to approve the previously announced proposed sale of the Company’s VOWST business to Société des Produits Nestlé S.A. Seres will file a Current Report on Form 8-K with the SEC ...
Seres publicly listed on the Nasdaq under the symbol MCRB in June 2015, raising $134M. [8] Seres signed a partnership valued at $2B with Nestle Health Sciences in early 2016. [9] In 2014, Berry founded Indigo Agriculture to create seed treatments that optimize the health of a plant to increase yield. [10] The same year, Berry founded Evelo ...
Nestle's unit will pay an undisclosed payment to Massachusetts-based Seres, and the drug maker will also receive capital infusions, the companies said. Vowst fits within Nestle Health Science's ...
In this article we are going to estimate the intrinsic value of Seres Therapeutics, Inc. ( NASDAQ:MCRB ) by taking the... Skip to main content. 24/7 Help. For premium support please call: 800-290 ...